Expression of C-MYB and B-MYB Oncogenes on Myelofibrotic Marrow Fibroblasts

References

• Ward H. P., Block M. H. The natural history of agno‐genic myeloid metaplasia (AMM) and a critical evaluation of its relationship with myeloproliferative syndrome. Medicine 1971; 50: 357–420
   PubMed Web of Science ®Google Scholar
• Burstein S. A., Malpass T. W., Yee E., Kadin M., Brigden M., Adamson J. W., Harker L. A. Plateled factor‐4 excretion in myeloproliferative disease: implication for the aetiology of myelofibrosis. British Journal of Haematology 1984; 57: 383–392
   PubMed Web of Science ®Google Scholar
• Castro‐Malaspina H. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components. Myelofibrosis and the biology of connective tissue, P. D. Berk, H. Castro‐Malaspina, L. R. Wasserman. Alan R. Liss, INC, New York 1984; 427–454
   Google Scholar
• Bernabei P. A., Arcangeli A., Casini M., Grossi A., Pado‐vani R., Ferrini P. R. Plateled‐derived growth factors) mitogenic activity in patients with myeloproliferative disease. British Journal of Haematology 1986; 63: 353–357
   PubMed Web of Science ®Google Scholar
• Katoh O., Kimura A., Kuramoto A. Plateled‐derived growth factors is decreased in patients with myeloproliferative disorders. American Journal of Haematology 1988; 27: 276–280
   PubMed Web of Science ®Google Scholar
• Kimura A., Katoh O., Kuramoto A. Effects of plateled derived growt factor, epidermal growth factors and transforming growth factors B on the growth of human marrow fibroblast. British Journal of Haematology 1988; 69: 9–12
   PubMed Web of Science ®Google Scholar
• Kimura A., Katoh O., Hyodo H., Kuramoto A. Trasforming growth factor B regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. British Journal of Haematology 1989; 72: 486–491
   PubMed Web of Science ®Google Scholar
• Donald G., Forrest P. L., Eastham J. M., Reilly J. T. Reduced plateled PDGF levels in idiopathic myelofibrosis. British Journal of Haematology 1991; 78: 586–588
   PubMed Web of Science ®Google Scholar
• Martyre M., Magdelenat H., Bryckaert M., Laine‐Bidron C., Calvo F. Increased intraplatelet levels of platelet‐derived growth factors‐B in patients with myelofibrosis with myeloid metaplasia. British Journal of Haematology 1991; 77: 80–86
   PubMed Web of Science ®Google Scholar
• Hasselbach H. C. [diopatic myelofibrosis‐an update with particular reference to clinical aspects and prognosis. International Journal of Clinical & Laboratory Research 1993; 23: 124–138
   PubMedGoogle Scholar
• Lüscher B., Eisenman R. N. New light on Myc and Myb. Part II. Myb. Genes & Development 1990; 4: 2235–2241
   PubMed Web of Science ®Google Scholar
• Mucenski M. L., McLain K., Kier A. B., Swerdlow S. H., Schreiner C. M., Miller T. A., Peitryga D. W., Scott W. J., Jr, Potter S. S. A functional c‐myb is required for normal murine fetal hepatic hematopoiesis. Cell 1991; 65: 677–689
   PubMed Web of Science ®Google Scholar
• Melani C., Rivoltini L., Parmiani B., Calabretta B., Colombo M. Inhibition of proliferation by c‐myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c‐myb. Cancer Research 1991; 51: 2897–2901
   PubMed Web of Science ®Google Scholar
• Hoffman Liebermann B., Liebermann D. A. Suppression of c‐Myc and c‐myb is tightly linked to terminal differentiation induced by IL‐6 or LIF and not growth inhibition in myeloid leukemia cells. Oncogene 1991; 6: 903–909
   PubMed Web of Science ®Google Scholar
• Selvakumaran M., Liebermann D. A., Hoffman Liebermann B. Deregulated c‐myb disrupts interleukin 6‐or leukemia inhibitory factor‐induced myeloid differentiation prior to c‐myc: Role in leukemogenesis. Molecular and Cellular Biology 1992; 12: 2493–2500
   PubMed Web of Science ®Google Scholar
• Simons M., Edelman E. R., Dekeyser J. L., Langer R., Rosenberg R. D. Antisense c‐myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 1992; 359: 67–70
   PubMed Web of Science ®Google Scholar
• Szczylik C., Skorski T., Ku D. ‐H., Nicolaides N. C., Wen S. ‐C., Rudnicka L., Bonati A., Malaguarnera L., Calabretta B. Regulation of Proliferation and Cytokine Expression of Bone Marrow Fibroblasts: Role of c‐myb. Journal of Experimental Medicine 1993; 178: 997–1005
   PubMed Web of Science ®Google Scholar
• Arsura M., Luchetti M. M., Erba E., Golay J., Rambaldi A., Introna M. Dissociation Between p93 B‐myb and p 75 c‐myb Expression During the Proliferation and Differentiation of Human Myeloid Cells Lines. Blood 1994; 83: 1778–1790
   PubMed Web of Science ®Google Scholar
• Introna M., Luchetti M., Castellano M., Arsura M., Golay J. The myb oncogene family of transcription factors: Potent regulators of hematopoietic cell proliferation and differentiation. Seminars in Cancer Biology 1994; 5: 113–124
   PubMed Web of Science ®Google Scholar
• Nomura N., Takahashi M., Matsui M., Ishii S., Date T., Sasamoto S., Ishizaki R. Isolation of human cDNA clones of myb‐related genes, A‐myb and B‐myb. Nucleic Acids Research 1988; 16: 11075–11089
   PubMed Web of Science ®Google Scholar
• Reiss K., Travali S., Calabretta B., Barsega R. Growth Regulated Expression of B‐MYB in fibroblast and Hematopoietic Cell. Journal of Cellular Physiology 1991; 148: 338–343
   PubMed Web of Science ®Google Scholar
• Arsura M., Introna M., Passerini E., Mantovani A., Golay J. B‐myb antisense oligonucleotides inhibit proliferation of human haematopoietic cell lines. Blood 1992; 79: 2708–2716
   PubMed Web of Science ®Google Scholar
• Sala A., Calabretta B. Regulation of BALB/c 3T3 fibroblast proliferation by B‐myb is accompanied by selective activation of cdc 2 and cyclin D1 expression. Proceedings of The National Academy of Sciences of The United States of America 1992; 89: 10415–10419
   PubMed Web of Science ®Google Scholar
• Schultz A., Knor H. Comparative histological and clinical study on the staging of polycythemia vera and osteosclerosis. Pathology of the Bone Marrow, K. Lennert, K. Hubner. Gustav Fisher, Stuttgart 1984; 177–181
   Google Scholar
• Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1989
   Google Scholar
• Belyavsky A., Vinogradova X., Rajevsky K. Pcr‐Based cDNA library construction: general cDNA libraries as the level of a few cells. Nucleic Acids Research 1989; 17: 2919–2932
   PubMed Web of Science ®Google Scholar
• Olson J. E., Winston J. T., Whintlock J. A., Pledger W. J. Cell Cycle Dependent Gene Expression in V Point‐Arrested BALB/C‐3T3 cells. Journal of Cellular Physiology 1993; 154: 333–342
   PubMed Web of Science ®Google Scholar
• Lam E. W.‐E., Robinson C., Watson R. J. Characterization and cell cycleregulated expression of mouse B‐myb. Oncogene 1992; 7: 1885–1890
   PubMed Web of Science ®Google Scholar
• Damashek W. Some speculations on the myeloproliferative disorders. Blood 1951; 6: 372–375
   PubMed Web of Science ®Google Scholar
• Jacobson R. J., Salo A., Fialkow P. J. Agnogenic myeloid metaphasia: a clonal proliferation of haematopoietic stem cells with secondary myelofibrosis. Blood 1978; 51: 189–194
   PubMed Web of Science ®Google Scholar
• Whang‐Peng J., Lee E., Knutsen T., Chang P., Nienhuis A. Cytogenetic studies in patients with myelofibrosis and myeloid metaplasia. Leukaemia Research 1978; 2: 41–56
   Web of Science ®Google Scholar
• Castro‐Malaspina H., Gay R. E., Thanwar S. L. Characteristics of bone marrow fibroblast colony forming cells and their progeny in patients with myeloproliferative disorders. Blood 1982; 59: 1046–1056
   PubMed Web of Science ®Google Scholar
• Groopman J. E. The pathogenesis of myelofibrosis in myeloproliferative disorders. Annals of Internal Medicine 1980; 92: 857–865
   PubMed Web of Science ®Google Scholar
• Kimura A., Katoh O., Hyodo H., Kusumi S., Kuramoto A. Autocrine and/or paracrine mechanism operate during the growth of human bone marrow fibroblasts. British Journal of Haematology 1991; 78: 469–473
   PubMed Web of Science ®Google Scholar
• Piccinini G., Luchetti M. M., Caniglia M. L., Carossino A. M., Montroni M., Introna M., Gabrielli A. C‐myb proto‐oncogene is expressed by quiescent scleroderma fibroblasts and, unlike B‐myb gene, does not correlate with proliferation. The Journal of Investigative Dermatology 1996; 106: 1281–1286
   PubMed Web of Science ®Google Scholar
• Travali S., Reiss K., Ferber A., Petralia S., Mercer W. E., Calabretta B., Baserga R. Constitutively expressed c‐myb abrogates the requirement for IGF‐1 in 3T3 fibroblasts. Molecular and Cellular Biology 1991; 11: 731–736
   PubMed Web of Science ®Google Scholar